Molecular immune pathogenesis and diagnosis of COVID-19 / 药物分析学报
Journal of Pharmaceutical Analysis
;
(6): 102-108, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-823987
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coro-navirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
Idioma:
Chino
Revista:
Journal of Pharmaceutical Analysis
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS